Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

Food choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer

Authors: BM Parry, JM Lawrence, L Storey, JE Brown, DB Clarke, M Raats, SM Horton, JM Stilwell, RM Rainsbury

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

Phytoestrogens are plant-derived, bioactive substances with a chemical structure similar to that of 17β-oestradiol. Women previously treated for breast cancer may increase their phytoestrogen intake to avoid conventional hormone replacement therapy or because of a belief that they may help avoid recurrence [1, 2]. There is no recommended daily intake and there are some concerns about phytoestrogen safety in this group, although the evidence is conflicting and more research is needed [3, 4]. …
Literature
1.
Adlercreutz H: Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol. 2002, 83: 113-118. 10.1016/S0960-0760(02)00273-X.CrossRefPubMed
2.
Mills E, Ernst E, et al: Health food store recommendations: implications for breast cancer patients. Breast Cancer Res. 2003, 5: R170-R174. 10.1186/bcr636.CrossRefPubMedPubMedCentral
3.
De Lemos M: Safety issues of soy phytoestrogens in breast cancer patients. J Clin Oncol. 2002, 20: 3040-3041.PubMed
4.
Committee on Toxicology of Chemicals in Food, Consumer Products and the Environment: Phytoestrogens and Health. 2003, London: Food Standards Agency
Metadata
Title
Food choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer
Authors
BM Parry
JM Lawrence
L Storey
JE Brown
DB Clarke
M Raats
SM Horton
JM Stilwell
RM Rainsbury
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1976

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue

Poster presentation

Reelin expression in breast tumours is associated with increased survival and is controlled by promoter methylation

Poster presentation

Lymphovascular invasion in breast cancer: improved methods of detection and clinical significance

Poster presentation

Breast cancer and environmental risk factors: an appraisal of the scientific evidence

Poster presentation

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer

Poster presentation

Identification and definition of novel clinical phenotypes of breast cancer through consensus derived from automated clustering methods

Poster presentation

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits